Search | IOVS | ARVO Journals

View

Showing 1 – 13 of 13

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Neuroprotection of SARM1 Inhibition in Traumatic and Glaucomatous but not in EAE Optic Neuropathies

Pingting Liu; Haoliang Huang; Wei Chen; Fang Fang; Liang Li; Xue Feng; Liang Liu; Dong Liu; Roopa Dalal; Yang Sun; Karen Ling; Frank Rigo; Yang Hu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1136. doi:

ARVO Annual Meeting Abstract June 2022

Combination ASO therapy improves therapeutic benefits in a mouse model of Usher syndrome

Bhagwat V Alapure; Katelyn N Robillard; Mark Fisher; Frank Rigo; Jennifer J Lentz

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3174 – F0448. doi:

ARVO Annual Meeting Abstract June 2021

Antisense oligonucleotide treatment restores retinal expression of phototransduction proteins in Usher mice

Bhagwat V Alapure; Katelyn N Robillard; Frank Rigo; Jessie Guidry; Jennifer J Lentz

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3066. doi:

ARVO Annual Meeting Abstract June 2020

Antisense oligonucleotides rescue differentially expressed proteins in the retina of Usher mouse model

Bhagwat V Alapure; Katelyn N Robillard; Frank Rigo; Jessie J Guidry; Jennifer J Lentz

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2444. doi:

ARVO Annual Meeting Abstract June 2020

Optimizing oligotherapeutics for visual loss in Usher syndrome mice

Jennifer J Lentz; Marianne Hathaway; Katelyn N Robillard; Abhilash Ponnath; Mark Fisher; Frank Rigo; Bhagwat V Alapure

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2445. doi:

ARVO Annual Meeting Abstract July 2019

Duplex RNAs and ss-siRNAs Block RNA Foci Associated with Fuchs’ Corneal Endothelial Dystrophy

Vinod V Mootha; Jiaxin Hu; Xiulong Shen; Frank Rigo; Thahza Prakash; David Corey

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3879. doi:

ARVO Annual Meeting Abstract July 2018

Next Generation Sequencing characterizes disease progression in a murine model of Usher syndrome

Katelyn Nichole Robillard; Marianne Hathaway; Frank Rigo; Jennifer J Lentz

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2343. doi:

ARVO Annual Meeting Abstract July 2018

Long-term rescue of vision with antisense oligonucleotides in a mouse model of Usher syndrome

Jennifer J Lentz; Russell Amato; Robert Rosencrans; Francine Jodelka; Frederic F Depreux; Bhagwat V Alapure; Nicolas G Bazan; Frank Rigo; Michelle Hastings

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4523. doi:

ARVO Annual Meeting Abstract September 2016

Cumulative dosing enhances the beneficial effects of antisense oligonucleotide treatment on visual function in a mouse model of Usher Syndrome.

Russell Amato; Robert Follett Rosencrans; Francine M Jodelka; Frederic Depreux; Nicolas G Bazan; Frank Rigo; Michelle Hastings; Jennifer J Lentz

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):285. doi:

ARVO Annual Meeting Abstract June 2015

Early effects of antisense oligonucleotide treatment on photoreceptor function and retinal structure in a mouse model of Usher Syndrome

Russell J Amato; Robert Rosencrans; Francine M Jodelka; Anthony J Hinrich; Nicolas G Bazan; Frank Rigo; Michelle L Hastings; Jennifer J. Lentz

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5452. doi:

ARVO Annual Meeting Abstract June 2013

Treatment of Usher syndrome with antisense oligonucleotides

Jennifer Lentz; Mette Flaat; Francine Jodelka; Anthony Hinrich; Yongdong Zhou; Kate McCaffery; Dominik Duelli; Nicolas Bazan; Frank Rigo; Michelle Hastings

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1578. doi:

ARVO Annual Meeting Abstract March 2012

Correction of Cryptic Splicing in Usher Syndrome Using Antisense Oligonucleotides

Jennifer J. Lentz; Francine M. Jodelka; Anthony J. Hinrich; Kate E. McCaffrey; Hamilton E. Farris; Nicolas G. Bazan; Dominik M. Duelli; Frank Rigo; Michelle L. Hastings

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1900. doi:

ARVO Annual Meeting Abstract April 2011

Blocking Cryptic Splicing In Usher Syndrome Using Antisense Oligonucleotides

Kate E. McCaffrey; Anthony J. Hinrich; Francine M. Jodelka; Jennifer J. Lentz; Nick G. Bazan; Frank Rigo; Frank Bennett; Michelle L. Hastings

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3322. doi:

Advertisement